Compugen Ltd


Market Cap$186.51M

Compare Compugen Ltd

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Compugen LtdCompugen Ltd-5.50%-37%--
marketMarket Avg54.31.27%32%-1.3
HealthcareHealthcare Avg39.11.36%17%7.21.3

Current Fair Value

18.8% upside

Undervalued by 18.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$186.51 Million
Enterprise Value$89.58 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.39
Outstanding Shares89,237,465
Avg 30 Day Volume308,997


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.54
Price to Sales-
Price to Book Ratio2.14
Enterprise Value to Revenue14.93
Enterprise Value to EBIT-2.58
Enterprise Value to Net Income-3
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Compugen Ltd

CEO: Anat Cohen-Dayag

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immu...